Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Celebrating collaboration between UCL and industry

Publication date: Aug 29, 2013 02:28 PM

Start: Oct 07, 2013 05:00 PM
End: Oct 07, 2013 08:00 PM

Location: Torrington Place, London Borough of Camden, England, WC1E 6BT GB

Please join us to celebrate the efforts and accomplishments co-funded by the EPSRC’s Collaborative Training Account.

The CTA ended on 30 June 2013 and we are taking this opportunity to highlight the many successes that this grant has made possible by stimulating the collaboration between industry and UCL.

Presentations will be followed by a reception, which will provide an opportunity to meet the speakers, as well as many other innovators, and to find out more about their work.

17:00-17:30 Registration and drinks

17:30-18:45 Presentations:

  • Introduction - Professor Stephen Caddick, Vice-Provost (Enterprise)
  • Small fibres, big potential - Professor Mohan Edirisinghe, Department of Mechanical Engineering
  • An energy revolution: EIL helping to bring hydrogen-based energy to market - Dr Dan Brett, Department of Chemical Engineering
  • Water, water everywhere, nor any a drop to drink? - Dr Willy Burgess, Department of Earth Sciences
  • CHIRP Demonstration - Patrick Bergel, CEO Chirp.io
  • Closing remarks - Tim Barnes, Director UCL Advances & Enterprise Operations

18:45-20:00 Interactive displays, networking and drinks reception

20:00 End

Register for this event